Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 2 pages · English
Goldline Pharmaceutical Ltd. on 6ix
Earlier from Goldline Pharmaceutical
- Goldline Pharmaceutical Ltd. Press Release Sep 01 2026
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Goldline Pharmaceutical Ltd. Press Release Aug 31 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Follow Goldline Pharmaceutical into a list and get an email when it puts out news.
Follow Goldline Pharmaceutical